InsidersTradesSigma
Track the VERACYTE INC COM share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.5bn. The latest transaction was reported on 4 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: REBECCA CHAMBERS. All data is accessible without an account.
Analysts rate VERACYTE INC COM Buy (bullish), based on 11 analysts. Average price target: US$57.82.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Veracyte Inc es una empresa de diagnóstico molecular que ofrece pruebas para ayudar en la toma de decisiones clínicas en el sector de la salud. Cotiza en NASDAQ bajo el símbolo VCYT.